Top 5 Drug Type | Count |
---|---|
Small molecule drug | 22 |
Herbal medicine | 13 |
Monoclonal antibody | 2 |
Chemical drugs | 2 |
Target- |
Mechanism- |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date31 Oct 2021 |
Target- |
Mechanism- |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date21 Sep 2020 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date02 Jun 2020 |
Start Date08 Oct 2023 |
Sponsor / Collaborator |
Start Date02 Sep 2023 |
Sponsor / Collaborator |
Start Date19 Aug 2023 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Lumefantrine | Malaria More | Approved |
Artemether ( ATP2A1 x SERCA2 ) | Malaria More | Approved |
Clobetasol Propionate ( GR ) | Psoriasis More | Approved |
Pidotimod | Urinary Tract Infections More | Approved |
Cinobufagin Oral Liquid | Hepatitis B, Chronic More | Approved |